NLR and PLR Ratios - Accessible and Affordable Predictors of Disease Severity in COPD

Likitha Gutta,Shankarappa M,Tanveer Ahmed
Abstract:COPD is currently the fourth leading cause of death the world but is projected to be 3rd leading cause of death by 2020. It is characterized by limitation of airflow which is not fully transformable to normal along with increased long term inflammatory response in airways of the tracts of lungs. Acute exacerbations of COPD (AECOPD) are the most common causes of hospitalization and death among COPD patients. CRP, leukocytes, IL-6, IL-8 and fibrinogen are associated with COPD. However, while these biomarkers may be helpful, many of them are time consuming with extra cost, and some of the tests are not readily clinically available. Neutrophil-to-Lymphocyte Ratio (NLR) and platelet lymphocyte ratio (PLR) are effortless and basic parameters that are readily obtained from the simplest and easily obtainable complete blood count, even in peripheral hospitals. Material: Study was conducted at NMCH &RC, Raichur, patients attending NMCH for a duration of 18 months. 100 patients with a confirmed diagnosis of COPD confirmed with pulmonary function test according to GOLD criteria were included in the study. Observation: Mean age of the study population was 67.14±8.03 years. Males were predominant with male to female ratio as 9:1.Mean NLR of the AECOPD patients from stage 1 was 3.73±0.18, stage 2 was 6.07±1.27, stage 3 was 6.02±1.14 and stage 4 was 8.19±2.66. When we compared the mean NLR of the patients between different stages of COPD, the difference was found to be statistically significant (p<0.05). It means mean NLR was higher in stage 4 as compared to other groups. Mean PLR of the AECOPD patients from stage 1 was 12690.48±3978.45, stage 2 was 22219.93±7797.9, stage 3 was 19158.73±5070.88 and stage 4 was 19544.87±10207.59. When we compared the mean PLR of the patients between different stages of COPD, the difference was found to be statistically significant (p<0.05). It means mean PLR was higher in stage 2 followed by stage 4 as compared to other groups Conclusion: The NLR and PLR may be used as a useful and easily accessible tool for evaluating the ongoing inflammation during stable period and the disease severity during acute exacerbations in COPD patients. NLR ratio is more specific to severity of COPD compared to PLR ratio.
What problem does this paper attempt to address?